Skip to main content
. Author manuscript; available in PMC: 2024 Oct 9.
Published in final edited form as: J Allergy Clin Immunol. 2024 Apr 8;153(6):1621–1633. doi: 10.1016/j.jaci.2024.02.019

FIG 5.

FIG 5.

Theme K key statements regarding “OIT may be discontinued by patient or practitioner if…” Statement number and statement are listed. Percentage of participants who voted for statement represented by number and graphically as blue circle. Blue dots represent number of rounds to reach consensus. Median priority to include statement on consent form represented with number and rainbow lever graphic representation. Interquartile range listed below. Full list of statements is provided in Table E12.